Previous Article | Next Article 
Applied and Environmental Microbiology, June 2001, p. 2430-2435, Vol. 67, No. 6
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.6.2430-2435.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of the Properties of Human- and
Dairy-Derived Probiotics for Prevention of Infectious Diseases in
Fish
Sami
Nikoskelainen,1,2,*
Seppo
Salminen,1
Göran
Bylund,2 and
Arthur C.
Ouwehand1
Department of Biochemistry and Food
Chemistry, University of Turku, 20014 Turku,1
and Institute of Parasitology, Department of Biology,
Åbo Akademi University, 20520 Turku,2
Finland
Received 28 July 2000/Accepted 13 March 2001
 |
ABSTRACT |
The present study aimed to investigate the potential
probiotic properties of six lactic acid bacteria (LAB) intended for
human use, Lactobacillus rhamnosus ATCC 53103, Lactobacillus casei Shirota, Lactobacillus
bulgaricus, L. rhamnosus LC 705, Bifidobacterium lactis Bb12, and Lactobacillus johnsonii La1, and one
for animal use, Enterococcus faecium Tehobak, for use as a
fish probiotic. The strains for human use were specifically chosen
since they are known to be safe for human use, which is of major
importance because the fish are meant for human consumption. The
selection was carried out by five different methods: mucosal adhesion,
mucosal penetration, inhibition of pathogen growth and adhesion, and
resistance to fish bile. The adhesion abilities of the seven LAB and
three fish pathogens, Vibrio anguillarum, Aeromonas
salmonicida, and Flavobacterium
psychrophilum, were determined to mucus from five different sites on the surface or in the gut of rainbow trout. Five of
the tested LAB strains showed considerable adhesion to different fish
mucus types (14 to 26% of the added bacteria). Despite their adhesive
character, the LAB strains were not able to inhibit the mucus binding
of A. salmonicida. Coculture experiments showed
significant inhibition of growth of A. salmonicida, which was mediated by competition for nutrients rather than secretion of
inhibitory substances by the probiotic bacteria as measured in spent
culture liquid. All LAB except L. casei Shirota showed tolerance against fish bile. L. rhamnosus ATCC 53103 and L. bulgaricus were found to penetrate fish mucus better
than other probiotic bacteria. Based on bile resistance, mucus
adhesion, mucus penetration, and suppression of fish pathogen growth,
L. rhamnosus ATCC 53103 and L. bulgaricus can
be considered for future in vivo challenge studies in fish as a novel
and safe treatment in aquaculture.
 |
INTRODUCTION |
Aeromonas salmonicida
subsp. salmonicida is the causative agent of the fish
disease called furunculosis. It is one of the most common fish diseases
in Finland, along with vibriosis, caused by Vibrio
anguillarum. These diseases may cause major economic losses in
hatcheries. The port of entry of these pathogens has not been
identified, but the gastrointestinal tract has been implicated as a
site of colonization and a possible port of entry (8). The
third major fish disease, cold water disease, is caused by Flavobacterium psychrophilum (4), which affects
primarily juvenile salmonid fish (13).
Currently, either treatment with chemotherapeutic agents or vaccination
is used to protect fish against different bacterial diseases in
hatchery conditions. The former method may alter the profile of a
healthy gut microflora, while the latter is stressful for fish; both
methods may enable the access of some pathogens. The use of
chemotherapeutic agents has also led to occurrence of resistant
bacteria (22), and thus their use should be restricted. Both methods are also quite expensive. Preventing diseases in juvenile
fish is of significant economic importance, since small fish have high
mortality rates and are too small for vaccination.
Probiotics may provide an alternative way to reduce the use of
antibiotics in aquaculture and simultaneously avoid the development of
antibiotic-resistant bacteria. Probiotics are microbial cell preparations or components of microbial cells that have a beneficial effect on the health and well-being of the host (19).
Selected probiotics have been shown to have significant health benefits for humans, and thus several well-characterized strains are available for human use to reduce the risk of gastrointestinal infections or to
treat such infections (18, 19). Probiotics may provide a
potential support or alternative to vaccinations and treatment with
antibiotics in fish farming.
Adhesion to the intestinal mucosa is regarded a prerequisite for
colonization (3) and is one of the main selection criteria for new probiotic strains (7, 18). Adhesion to and
colonization of the mucosal surfaces are possible protective
mechanisms against pathogens through competition for binding
sites and nutrients (25), steric hindrance, or immune
modulation (18). Other important characteristics for
potential probiotics are tolerance to low pH and bile (7, 18,
19). The probiotic strains tested here are acid resistant.
Resistance to fish bile has not been tested earlier.
New probiotic candidates for fish have been investigated in many
studies; these include Vibrio alginolyticus
(1), Carnobacterium sp. (17),
Carnobacterium sp. strain K (9), and
unidentified strains (15). The aim of the present study
was to examine the potential of human probiotics for use in fish
because these probiotics have documented health effects and have been
shown to be safe for humans. The latter is of major importance since
the fish are farmed mainly for human consumption. These extensively
studied probiotics may also have applications in fish farming.
 |
MATERIALS AND METHODS |
Adhesion analysis.
V. anguillarum 1-284, F. psychrophilum T1-1, and A. salmonicida SN1 were
isolated from rainbow trout (Oncorhynchus mykiss) at the
Institute of Parasitology, Department of Biology, Åbo Akademi
University, Turku, Finland, during a natural outbreak of the diseases.
V. anguillarum and A. salmonicida were grown in tryptic soy broth (TSB; Difco) overnight at 20°C, while F. psychrophilum was grown in TYES broth (0.4% tryptone, 0.05%
yeast extract, 0.05% MgSO4 · 7H2O,
0.02% CaCl2 · 2H2O [pH 7.2]) for 2 days at 15°C with agitation. The following probiotic strains were
used: Lactobacillus rhamnosus ATCC 53103, Lactobacillus casei Shirota, Lactobacillus
delbrueckii subsp. bulgaricus ATCC 11842, L. rhamnosus LC 705, Bifidobacterium lactis Bb12,
and Lactobacillus johnsonii La1 (all intended for human use)
plus Enterococcus faecium Tehobak (intended for animal use).
The strains were a generous gift from M. Saxelin (Valio Ltd., Helsinki,
Finland). All probiotic strains were grown under anaerobic conditions
in MRS broth (Merck, Darmstadt, Germany) overnight at 37°C. To the
medium, tritiated thymidine
([methyl-1,2-3H]thymidine; 10 µl/ml, 117 Ci/mmol) was added to metabolically radiolabel the bacteria. After
incubation, the cells were harvested by centrifugation
(2,000 × g), washed twice with phosphate-buffered saline (PBS; 10 mM phosphate [pH 7.2]), and resuspended in PBS. The
absorbance at 600 nm was adjusted to 0.25 ± 0.05 in order to
standardize the number of bacteria (107 to 108
CFU/ml). The relationship between absorbance at 600 nm and CFU per
milliliter was established by flow cytometry (23).
Mucus preparation.
The fish used for the preparation of
mucus and bile were obtained from the Finnish Game and Fisheries
Research Institute, Laukaa, Finland. They were kept in quarantine in
freshwater for 2 weeks without any signs of disease. Mucus samples were
isolated from four 400-g healthy rainbow trout immediately after
sacrifice according to the method of Cohen and Laux (6).
The mucus was obtained by gently scraping the surfaces with a rubber
spatula into a small amount of HEPES (10 mM; pH 7.4)-buffered Hanks'
balanced salt solution (HH). The skin mucus was collected from the
whole body, and gill mucus was isolated after removing the gills. For intestinal mucus, the intestine was separated from the internal organs
and divided in three parts
esophagus, stomach, and intestine
from which mucus was collected separately. The mucus samples were stored in
1-ml aliquots at
70°C until use.
Mucus characterization.
Before use, the protein
concentration was determined by a modification of the method of Lowry
et al. (11) as described by Miller and Hoskins
(14), using bovine serum albumin (BSA; Sigma, St. Louis,
Mo.) as a standard. The mucus was used at a protein concentration of
0.5 mg/ml in HH.
In vitro adhesion assay.
Adhesion of the radioactively
labeled bacteria was determined as described by Kirjavainen et al.
(10). In brief, mucus was immobilized on microtiter plate
wells by overnight incubation at 4°C. Excess mucus was removed by
washing with HH. Radioactively labeled bacteria (see above) were added,
and the wells were incubated for 1 h at 37°C. Nonbound bacteria
were removed by washing with HH. Bound bacteria were released and lysed
by incubation at 60°C for 1 h with 1% sodium dodecyl sulfate
(SDS) in 0.1 M NaOH. Adhesion was assessed by quantitating the amount
of radioactivity by liquid scintillation and was expressed as the
percentage of radioactivity recovered after adhesion relative to the
radioactivity in the bacterial suspension added to the immobilized
mucus. Adhesion of the bacteria was determined in at least three
independent experiments for each mucus type, and each assay was
performed in triplicate to correct for intra-assay variation.
Nonspecific adhesion of probiotic bacteria.
To determine if
the observed mucus adhesion of the probiotic bacteria was due to
nonspecific adhesion, adhesion of the strains to BSA, gelatin, and
polystyrene was assessed. Adhesion to BSA, gelatin, and polystyrene was
determined as described above for mucus.
Competitive adhesion.
Labeling and culture conditions were
as described above for the in vitro adhesion assay. Nonlabeled
probiotic bacteria (100 µl; 107 to 108
CFU/ml) were allowed to bind to the immobilized mucus, for 1 h at
37°C. Nonbound probiotic bacteria were washed away with PBS. Subsequently, 100 µl of labeled A. salmonicida SN1 was
added to the wells and incubated for 1 h at 20°C. After unbound
labeled bacteria were washed away, bound bacteria were released and
lysed by incubation at 60°C for 1 h with 1% SDS in 0.1 M NaOH.
The adhesion of A. salmonicida was determined as described
above for the in vitro adhesion assay. Since the mucus adhesion of
F. psychrophilum and V. anguillarum was found to
be very low (1% or less), no competitive exclusion by probiotic
bacteria was assessed for these strains.
Growth inhibition by spent culture liquid.
To assess the
production of possible antimicrobial substances, five of the probiotic
bacteria which exhibited good adhesion to intestinal mucus, L. rhamnosus ATCC 53103, E. faecium Tehobak, L. bulgaricus, B. lactis Bb12, and L. johnsonii La1, were grown in 10 ml of MRS overnight at 37°C. The
bacteria were removed by centrifugation (2,000 × g),
and spent culture supernatants were sterilized by passage through
0.22-µm-pore-size filters. After sterilization, half (5 ml) of each
spent culture supernatant was neutralized (pH 7.0) with 5 N NaOH.
The fish pathogens V. anguillarum and A. salmonicida were grown in 1 ml of TSB overnight at 20°C. The
cells were harvested by centrifugation (2,000 × g),
washed twice with PBS, and resuspended in 1 ml of PBS. The bacterial
suspensions were transferred evenly on tryptic soy agar (TSA; Difco)
plates. Four wells were made in each agar plate with a sterile pasteur
pipette; 50 µl of neutralized and 50 µl of untreated spent culture
supernatant from the five different lactic acid bacteria were added to
the wells. In two wells, neutralized MRS and MRS (pH 5.59) were added
to determine possible inhibitory activity of the medium. After aerobic
incubation for 3 days at room temperature, the clearing zone was determined.
Growth inhibition by coculture.
Competition for nutrients is
one of the mechanisms by which probiotics are thought to affect
pathogenic microorganisms. This was assessed by growing each probiotic
strain with either A. salmonicida or V. anguillarum in coculture. F. psychrophilum was not
assessed in coculture because its optimal growth temperature is below
the temperature range of the probiotic strains. The probiotic strains will thus not cause competition.
Overnight cultures of the fish pathogens A. salmonicida SN1
and V. anguillarum 1-284 were washed twice with PBS, and
cell concentrations were adjusted to an absorbance at 600 nm of 0.5. Overnight cultures of probiotic bacteria L. rhamnosus ATCC 53103, L. johnsonii La1,
L. casei Shirota, L. bulgaricus, L. rhamnosus LC 705, B. lactis Bb12, and E. faecium Tehobak were treated similarly. Of each probiotic strain
and pathogen, 100 µl of bacterial suspension was mixed in 1 ml
of TSB and incubated for 2 days at 20°C. As a control, 100 µl of
PBS and pathogen suspension in TSB was used. After incubation, the
number of cells in each sample was determined by spreading appropriate
dilutions on MRS, TSA, and TCBS plates, for probiotic, A. salmonicida, and V. anguillarum enumeration, respectively. The results are expressed as percentage of pathogen growth in coculture with a probiotic strain compared to growth on its
own (control).
Fish bile resistance.
Bacterial suspensions were prepared in
PBS, and the absorbance at 600 nm was adjusted to 0.25 as described
above. A 500-µl aliquot of each bacterial suspension was centrifuged
and resuspended in sterile PBS or in sterile PBS with 10% fish bile.
The bile was collected from rainbow trout by puncturing the gallbladder and stored at
20°C until use. Samples were incubated for 1.5 h
at 37°C. After incubation, samples were serially diluted in sterile
PBS, and viable counts were determined by plate counting using MRS agar
and TSA for the probiotic strains and fish pathogens, respectively.
Mucus penetration.
The intestinal mucus was diluted to a
protein concentration of 3 mg/ml with HH. After dilution, the
penetration assay was performed as described by Cohen and Laux
(6). In short, 50 µl of diluted mucus sample was added
to microtiter plate wells. On top of the mucus samples, 20 µl of
radiolabeled bacterial suspension was applied; the bacterial
suspensions were prepared as described above. The wells of the
microtiter plate (two wells for each bacterial sample and each
incubation time) were incubated for 1.5, 3, 4.5, and 6 h at room
temperature. After incubation, the wells were emptied. To lyse the
penetrated bacteria, 200 µl of 1% SDS-0.1 M NaOH was added to each
well, and the plate was incubated at 60°C for 1 h. The lysate
was removed from the wells and mixed with scintillation liquid
(OptiPhase HiSafe 3; Wallac, Loughborough, United Kingdom), and the
radioactivity was measured by liquid scintillation counting. The
proportion of penetrated bacteria was assessed as the percentage of
radioactivity recovered from the wells compared to the radioactivity of
the added bacterial suspension on top of the mucus.
Statistical analysis.
All results are shown as the average
of at least three independent experiments; variation is expressed as
standard deviation. Student's t test was used to determine
the significant difference (P < 0.05) between
different tested groups.
 |
RESULTS |
Adhesion of pathogens.
All three tested fish pathogen strains
tended to adhere in relatively low numbers or not at all to the five
different fish mucus preparations tested (0 to 3.7% adhesion
[Fig. 1]). The lowest adhesion was
observed for F. psychrophilum, which adhered
below the detection limit to mucus isolated from the skin, esophagus, and gills. The tested fish pathogens did not show preferential binding
to mucus preparations isolated from different sites on the surface or
in the gut from rainbow trout (P > 0.05).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
Adhesion of three radioactively labeled fish pathogens,
A. salmonicida, V. anguillarum, and F. psychrophilum, to mucus preparations from five different sites on
the surface or in the gut of rainbow trout. Adhesion is expressed as
percentage of radioactivity recovered from the immobilized mucus
compared to radioactivity added to the mucus; error bars indicate SD.
|
|
Adhesion of probiotics.
The probiotic bacteria strains
L. rhamnosus ATCC 53103, L. bulgaricus,
B. lactis Bb12, and L. johnsonii La1 tended to adhere in high numbers to the different fish mucus types (13.1 to 27.1% adhesion [Fig. 2]).

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 2.
Adhesion of probiotic lactic acid bacteria to various
fish mucus types. Adhesion is expressed as percentage of radioactivity
recovered from the immobilized mucus compared to radioactivity added to
the mucus; error bars indicate SD. Adhesion of E. faecium to
mucus from gill and skin is significantly (*, P < 0.0001) different from mucus from esophagus, stomach, and
intestine.
|
|
L. casei Shirota and L. rhamnosus LC 705 adhered to fish mucus in low numbers (0.3 to 5.9% adhesion [Fig.
2]). E. faecium was found to adhere well to mucus
from the intestine, stomach, and esophagus (around 15%) but
significantly less (P < 0.0001) to the mucus from
gills and skin (around 2.5%) (Fig. 2). For the other tested probiotic
strains, no significant difference in adhesion to the five different
mucus preparations was observed. The adhesion of L. casei
Shirota to all tested mucus preparations was significantly (P < 0.05) different from that of B. lactis Bb12, L. bulgaricus, L. johnsonii La1, and
L. rhamnosus ATCC 53103. The adhesion of L. rhamnosus LC 705 to all tested mucus preparations
was significantly (P < 0.01) different from that
of B. lactis Bb12, L. bulgaricus, L. johnsonii La1, L. rhamnosus ATCC 53103, and
E. faecium.
Nonspecific adhesion.
Each tested strain adhered similar to
BSA and gelatin (P > 0.05). B. lactis Bb12,
L. bulgaricus, and L. rhamnosus
ATCC 53103 adhered significantly better to BSA and gelatin than the
other strains. With the exception of L. casei
Shirota, all strains adhered well to polystyrene. The strains
that were observed to bind well to intestinal mucus,
L. bulgaricus, B. lactis Bb12, L. johnsonii La1, L. rhamnosus ATCC 53103, and
E. faecium, adhered significantly less to gelatin and BSA
(Table 1).
Competitive adhesion.
The tested fish pathogen A. salmonicida tended to adhere in similar numbers to immobilized
fish mucus preparations (0.5 to 2.4% adhesion) regardless of the prior
binding of any of the tested probiotic bacteria (P > 0.05) (Table 2).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Competition of probiotic lactic acid bacteria toward
A. salmonicida for adhesion to fish intestinal and skin
mucus
|
|
Growth inhibition by spent culture liquid.
After incubation of
pathogens on TSA plates, no measurable clearing zones were detected
around the wells filled with neutralized or nonneutralized spent
culture liquid from the tested probiotic lactic acid bacteria.
Growth inhibition by coculture.
Upon 24 h growth in
coculture, all tested probiotic bacteria were found to significantly
inhibit the growth A. salmonicida (P < 0.05). However, only L. johnsonii La1 and L. casei Shirota significantly inhibited the growth of V. anguillarum (Table 3).
Fish bile resistance.
With the exception of L. casei Shirota, all strains, including the fish pathogens,
tolerated 1.5 h of incubation in the presence of 10% fish bile;
no significant changes in numbers of viable counts were observed
compared to the control. The viable count of L. casei
Shirota was reduced by 19.7% (SD = 5%; P < 0.001).
Mucus penetration.
L. rhamnosus ATCC 53103 and L. bulgaricus were found penetrate intestinal mucus
better than the other tested probiotic strains (P < 0.05) (Fig. 3). The differences
between other probiotic strains were not significant.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
Penetration of probiotic bacteria trough fish intestinal
mucus. The mucus concentration was adjusted to 3 mg/ml with HH. Wells
of the microtiter plate (two wells for each bacterial sample and each
incubation time) were incubated for 1.5, 3, 4.5, and 6 h at room
temperature. Penetrated bacteria were quantitated as percentage of
radioactivity recovered from the wells compared to radioactivity of the
added bacterial suspension on top of the mucus.
|
|
 |
DISCUSSION |
Interaction with mucus is the first step in adhesion of bacteria
to the intestinal mucosa and other mucosal surfaces. This may provide
competitive exclusion by probiotic microorganisms by blocking adhesion
receptors, competition for nutrients, and production of antimicrobial
substances. The result may be blockage of the ports of entry for fish
pathogens. The ability of the tested fish pathogens to adhere to
different mucus preparations of fish was low, and no clear preferential
binding for mucus from a certain site of the body was observed. Horne
and Baxendale (8) observed some differences between the
binding ability of V. anguillarum to different mucus types,
but these differences were small; Olsson and coworkers
(15) obtained similar results. However, the differences observed in the present study did not reach statistical significance, which may be explained by the use of a different V. anguillarum strain. However, A. salmonicida was
observed to adhere relatively well to all mucus types, which may help
to explain its virulence. The results do not suggest the possible ports
of entry of the pathogens in the fish, since no major differences in
adhesion to the different mucus types were observed.
An interesting observation was that most of the adhesive human
probiotic bacteria also bound well to fish mucus. Especially L. rhamnosus ATCC 53103, L. bulgaricus, L. johnsonii La1, and B. lactis Bb12 bound at similar
levels to fish mucus as to human intestinal mucus (16).
This also indicates that species specificity may not always be a factor
in terms of initial adhesion properties. The adhesion to mucus appeared
to be specific, since the adhesion of the above-mentioned strains to
BSA and gelatin was significantly less. Only L. rhamnosus LC 705 and L. casei Shirota exhibited similar adhesion to BSA and gelatin as to intestinal mucus, suggesting that the observed low adhesion to intestinal mucus is due mainly to
nonspecific adhesion. The high binding of most strains to polystyrene may indicate the importance of hydrophobic interactions in the adhesion
to intestinal mucus, as suggested by other workers (24). In contrast to the other tested bacteria, E. faecium
exhibited mucus specificity. It adhered to gill and skin mucus
significantly less well than to mucus from the other tested organs.
Because of the low binding capacity of the tested fish pathogens, the
effect of the tested probiotic strains on this adhesion was small or
not detectable, despite the high adhesive capacity of some of the
tested probiotic strains. Competition for nutrients was observed to
significantly reduce the growth of A. salmonicida, but only
two of the tested probiotic strains affected the growth of V. anguillarum. The probiotic strains were not observed to produce
any significant antimicrobial activity against the fish pathogens as
measured in spent culture liquid. This indicates that earlier reported
antimicrobial substances produced by L. rhamnosus
ATCC 53103 (21), L. bulgaricus
(20), and L. johnsonii La1 (5)
were either not produced or not effective against the tested pathogens.
The antimicrobial activity of L. bulgaricus was tested by a
slightly different method (20), which may also explain the
observed differences. Other mechanisms by which probiotics may affect
pathogens include binding of bacterial toxins, modulation of the immune
system, and stabilization of a normal gut microflora. These mechanisms
were, however, not assessed here. All probiotic strains tested have
been reported to be acid and bile tolerant by the manufacturers. When
the probiotics are less sensitive to acid and bile, they are more
likely to survive passage through the gastrointestinal tract and may
colonize, albeit transiently, both the intestinal and other mucosal
surfaces of the fish. Of the tested probiotic strains, only L. casei Shirota was found to be sensitive to fish bile. It should,
however, be noted that the bile concentration used is relatively high.
In humans, the physiological concentration is estimated to be
approximately 3% in the upper small intestine. However, the
physiological concentration of bile for fish is not known.
Penetration through the mucus layer may be also an important property,
since the intestinal mucus layer is constantly being synthesized and
sloughed off. Organisms that can more easily penetrate and colonize
deep within the mucus layer may have an advantage in colonizing the
intestine (12). It remains to be explained how L. rhamnosus ATCC 53103 and L. bulgaricus
penetrate the mucus quicker than the other tested strains, since lactic
acid bacteria are, by definition, nonmotile (2).
The good adhesive ability, the ability of some strains to penetrate
mucus well, and the ability of most strains to suppress pathogen growth
in coculture, together with the observed stability against fish bile,
may indicate that probiotics intended for human use may provide safe
probiotics for use in the farming of fish for subsequent human
consumption. The most effective mucus-binding and mucus-penetrating
strains, L. bulgaricus and L. rhamnosus ATCC 53103, should be further studied in challenge experiments in fish
to observe their potential protective effectiveness for fish against
the opportunistic fish pathogens which cause economic losses in fish
farming. This approach may provide safe novel treatment and feeding
additives for fish farming.
 |
ACKNOWLEDGMENTS |
This study was supported by the Academy of Finland.
Satu Tölkkö and Pia Niemi are acknowledged for skillful
technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry and Food Chemistry, University of Turku, 20014 Turku,
Finland. Phone: 358-2-3336873. Fax: 358-2-3336860. E-mail:
sami.nikoskelainen{at}utu.fi.
 |
REFERENCES |
| 1.
|
Austin, B.,
L. F. Stuckey,
P. A. W. Robertson,
I. Effendi, and D. R. W. Griffith.
1995.
A probiotic strain of Vibrio alginolyticus effective in reducing diseases caused by Aeromonas salmonicida, V. anguillarum and V. ordalii.
J. Fish Dis.
18:93-96.
|
| 2.
|
Axellson, L.
1998.
Lactic acid bacteria: classification and physiology, p. 1-72.
In
S. Salminen, and A. von Wright (ed.), Lactic acid bacteria: microbiology and functional aspects, 2nd ed. Marcel Dekker, Inc, New York, N.Y.
|
| 3.
|
Beachey, E. H.
1981.
Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces.
J. Infect. Dis.
143:325-345[Medline].
|
| 4.
|
Bernardet, J. F.,
P. Segers,
M. Vancanneyt,
F. Berthe,
K. Kersters, and P. Vandamme.
1996.
Cutting a Gordian knot: emended classification and description of the genus Flavobacterium, emended description of the family Flavobacteriaceae, and proposal of Flavobacterium hydatis nom. nov. (basonym, Cytophaga aquatilis Strohl and Tait 1978).
Int. J. Syst. Bacteriol.
46:128-148[Abstract/Free Full Text].
|
| 5.
|
Bernet-Camard, M.-F.,
V. Liévin,
D. Brassart,
J.-R. Neeser,
A. L. Servin, and S. Hudault.
1997.
The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo.
Appl. Environ. Microbiol.
63:2747-2753[Abstract].
|
| 6.
|
Cohen, P. S., and D. C. Laux.
1995.
Bacterial adhesion to and penetration of intestinal mucus in vitro.
Methods Enzymol.
253:309-314[Medline].
|
| 7.
|
Havenaar, R.,
B. ten Brink, and J. H. J. Huis in't Veld.
1992.
Selection of strains for probiotic use, p. 209-224.
In
R. Fuller (ed.), Probiotics, the scientific basis, 1st ed. Chapman and Hall, London, England.
|
| 8.
|
Horne, M. T., and A. Baxendale.
1983.
The adhesion of Vibrio anguillarum to host tissues and its role in pathogenesis.
J. Fish Dis.
6:461-471[CrossRef].
|
| 9.
|
Jöborn, A.
1998.
The role of the gastrointestinal microbiota in the prevention of bacterial infections in fish. Ph.D. thesis.
Göteborg University, Gothenburg, Sweden.
|
| 10.
|
Kirjavainen, P. E.,
A. C. Ouwehand,
E. Isolauri, and S. J. Salminen.
1998.
The ability of probiotic bacteria to bind to human intestinal mucus.
FEMS Microbiol. Lett.
167:185-189[CrossRef][Medline].
|
| 11.
|
Lowry, O. H.,
N. J. Rosebourgh,
A. L. Farr, and R. J. Randall.
1951.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
19:265-275.
|
| 12.
|
Madsen, L., and I. Dalsgaard.
1999.
Reproducible methods for experimental infection with Flavobacterium psychrophilum in rainbow trout Oncorhynchus mykiss.
Dis. Aquat. Org.
36:169-176[Medline].
|
| 13.
|
McCormick, B. A.,
B. A. D. Stocker,
D. C. Laux, and P. S. Cohen.
1988.
Roles of motility, chemotaxis, and penetration through and growth in intestinal mucus in the ability of an avirulent strains of Salmonella typhimurium to colonize the large intestine of streptomycin-treated mice.
Infect. Immun.
56:2209-2217[Abstract/Free Full Text].
|
| 14.
|
Miller, R. S., and L. C. Hoskins.
1981.
Mucus degradation in human colon ecosystems. Faecal population densities of mucus degrading bacteria estimated by a `most probable number' method.
Gastroenterology
81:759-765[Medline].
|
| 15.
|
Olsson, J. C.,
A. Westerdahl,
P. L. Conway, and S. Kjelleberg.
1992.
Intestinal colonization potential of turbot (Scophthalmus maximus)- and dab (Limanda limanda)-associated bacteria with inhibitory effects against Vibrio anguillarum.
Appl. Environ. Microbiol.
58:551-556[Abstract/Free Full Text].
|
| 16.
|
Ouwehand, A. C.,
P. V. Kirjavainen,
M.-M. Grönlund,
E. Isolauri, and S. Salminen.
1999.
Adhesion of probiotic micro-organisms to intestinal mucus.
Int. Dairy J.
9:623-630[CrossRef].
|
| 17.
|
Robertson, P. A. W.,
C. O'Dowd,
C. Burrells,
P. Williams, and B. Austin.
2000.
Use of Carnobacterium sp. as a probiotic for Atlantic salmon (Salmo salar L.) and rainbow trout (Oncorhynchus mykiss, Walbaum).
Aquaculture
185:235-243[CrossRef].
|
| 18.
|
Salminen, S.,
C. Bouley,
M.-C. Boutron-Ruault,
J. H. Cummings,
A. Franck,
G. R. Gibson,
E. Isolauri,
M.-C. Moreau,
M. Roberfroid, and I. Rowland.
1998.
Functional food science and gastrointestinal physiology and function.
Br. J. Nutr.
80:S147-S171.
|
| 19.
|
Salminen, S.,
A. C. Ouwehand,
Y. Benno, and Y. K. Lee.
1999.
Probiotics: how should they be defined?
Trends Food Sci. Technol.
10:107-110[CrossRef].
|
| 20.
|
Shahani, K. M.,
J. R. Vakil, and A. Kilara.
1976.
Natural antibiotic activity of Lactobacillus acidophilus and bulgaricus. I. Cultural conditions for the production of antibiosis.
Cult. Dairy Prod. J.
11:14-17.
|
| 21.
|
Silva, M.,
N. V. Jacobus,
C. Deneke, and S. L. Gorbach.
1987.
Antimicrobial substance from a human Lactobacillus strain.
Antimicrob. Agents Chemother.
31:1231-1233[Abstract/Free Full Text].
|
| 22.
|
Smith, P.,
M. P. Hiney, and O. B. Samuelsen.
1994.
Bacterial resistance to antimicrobial agents used in fish farming: a critical evaluation of method and meaning.
Annu. Rev. Fish Dis.
4:273-313[CrossRef].
|
| 23.
|
Virta, M.,
S. Lineri,
P. Kankaanpää,
M. Karp,
K. Peltonen,
J. Nuutila, and E.-M. Lilius.
1998.
Determination of the complement-mediated killing of the bacteria by viability staining and bioluminescence.
Appl. Environ. Microbiol.
2:515-519.
|
| 24.
|
Wadström, T.,
K. Andersson,
M. Sydow,
L. Axelsson,
S. Lindgren, and B. Gullmar.
1987.
Surface properties of lactobacilli isolated from the small intestine of pigs.
J. Appl. Bacteriol.
62:513-520[Medline].
|
| 25.
|
Westerdahl, A.,
J. C. Olsson,
S. Kjelleberg, and P. L. Conway.
1991.
Isolation and characterization of turbot (Scophthalmus maximus)-associated bacteria with inhibitory effects against Vibrio anguillarum.
Appl. Environ. Microbiol.
57:2223-2228[Abstract/Free Full Text].
|
Applied and Environmental Microbiology, June 2001, p. 2430-2435, Vol. 67, No. 6
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.6.2430-2435.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Hjelm, M., Riaza, A., Formoso, F., Melchiorsen, J., Gram, L.
(2004). Seasonal Incidence of Autochthonous Antagonistic Roseobacter spp. and Vibrionaceae Strains in a Turbot Larva (Scophthalmus maximus) Rearing System. Appl. Environ. Microbiol.
70: 7288-7294
[Abstract]
[Full Text]